Browsing by Author Zalba, S. (Sara)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleTypeAuthor(s)
2012Application of different methods to formulate PEG-liposomes of oxaliplatin: Evaluation in vitro and in vivoArticuloZalba, S. (Sara); Navarro-Blasco, I. (Iñigo); Troconiz, I.F. (Iñaki F.); Tros-de-Ilarduya, C. (Conchita); Garrido, M.J. (María Jesús)
2015Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancerArticuloZalba, S. (Sara); Contreras, A.M. (Ana M.); Haeri, A. (Azadeh); Hagen, T.L.M. (Timo L.M.) ten; Navarro-Blasco, I. (Iñigo); Koning, G. (Gerben); Garrido, M.J. (María Jesús)
29-Jan-2019Design and in vitro / in vivo evaluation of a targeted immunotherapy platform for the treatment of melanomaTesisMerino-Díaz, M. (María)
2015Design and in-vitro/in-vivo evaluation in colon cancer cells of targeted oxaliplatin liposomes to epidermal growth factor receptor by conjugation of different ligandsTesisZalba, S. (Sara)
2021Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine modelArticuloMerino-Díaz, M. (María); Lozano-Moreda, T. (Teresa); Casares, N. (Noelia); Lana, H. (Hugo); Troconiz, I.F. (Iñaki F.); Hagen, T.L.M. (Timo L.M.) ten; Kochan, G. (Grazyna); Berraondo, P. (Pedro); Zalba, S. (Sara); Garrido, M.J. (María Jesús)
2020Quantification of pharmacokinetic profiles of PD-1/PD-L1 antibodies by validated ELISAsArticuloZalba, S. (Sara); Contreras-Sandoval, A.M. (Ana M.); Martisova, E. (Eva); Debets, R. (Reno); Smerdou, C. (Cristian); Garrido, M.J. (María Jesús)